NEW
YORK, May 29, 2024 /PRNewswire/ -- Sarepta
Therapeutics Inc. (NASD: SRPT) will replace Shockwave Medical Inc.
(NASD: SWAV) in the S&P MidCap 400 effective prior to the
opening of trading on Monday, June 3.
S&P 500 constituent Johnson & Johnson (NYSE: JNJ) is
acquiring Shockwave Medical in a deal expected to be completed soon
pending final closing conditions.
Following is a summary of the changes that will take place prior
to the open of trading on the effective date:
|
Effective
Date
|
Index
Name
|
Action
|
Company
Name
|
Ticker
|
GICS
Sector
|
|
June 3, 2024
|
S&P MidCap
400
|
Addition
|
Sarepta
Therapeutics
|
SRPT
|
Health Care
|
|
June 3, 2024
|
S&P MidCap
400
|
Deletion
|
Shockwave
Medical
|
SWAV
|
Health Care
|
For more information about S&P Dow Jones Indices, please
visit www.spdji.com
ABOUT S&P DOW JONES INDICES
S&P Dow Jones Indices is the largest global resource for
essential index-based concepts, data and research, and home to
iconic financial market indicators, such as the S&P 500® and
the Dow Jones Industrial Average®. More assets are invested in
products based on our indices than products based on indices from
any other provider in the world. Since Charles Dow invented the first index in 1884,
S&P DJI has been innovating and developing indices across the
spectrum of asset classes helping to define the way investors
measure and trade the markets.
S&P Dow Jones Indices is a division of S&P Global (NYSE:
SPGI), which provides essential intelligence for individuals,
companies, and governments to make decisions with confidence. For
more information, visit www.spdji.com.
FOR MORE INFORMATION:
S&P Dow Jones
Indices
index_services@spglobal.com
Media Inquiries
spdji.comms@spglobal.com
View original
content:https://www.prnewswire.com/news-releases/sarepta-therapeutics-set-to-join-sp-midcap-400-302158643.html
SOURCE S&P Dow Jones Indices
